Change in hemoglobin trajectory and darbepoetin dose approaching end-stage renal disease: Data from the trial to reduce cardiovascular events with aranesp therapy trial

Finnian R. Mc Causland, Brian Claggett, Marc A. Pfeffer, Emmanuel A. Burdmann, Kai Uwe Eckardt, Andrew S. Levey, John J.V. McMurray, Giuseppe Remuzzi, Ajay K. Singh, Scott D. Solomon, Robert D. Toto, Patrick Parfrey

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'Change in hemoglobin trajectory and darbepoetin dose approaching end-stage renal disease: Data from the trial to reduce cardiovascular events with aranesp therapy trial'. Together they form a unique fingerprint.

Medicine & Life Sciences